Square Enix Holdings Co., Ltd. - SQNXF

SQNXF Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
SQNXF	-1.4	-3.5	-4.7	10.6	11.6	12.3	-38.5	-18.8	103.3	78.6
S&P 500	-0.6	-0.5	2.3	7.3	12.1	32.1	27.0	90.7	191.4	33587.3

Compare SQNXF with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	SQNXF
name	Square Enix Holdings Co., Ltd.
price	37.05
changes percentage	-1.44
change	-0.54
day low	37.05
day high	37.05
year high	44.67
year low	27.98
market cap	4448132042
price avg 50	38.26
price avg 200	36.12
exchange	PNK
volume	100
avg volume	518
open	37.05
previous close	37.59
eps	0.54
pe	68.61
earnings announcement	2025-02-03T05:00:00.000+0000
shares outstanding	120057545
timestamp	2024-11-14 18:00:14

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 56.3%

Overall Quarterly Financial Health: 71.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	356344000000	343267000000	3.81
gross profit	163676000000	173016000000	-5.40
gross profit ratio	0.46	0.5	-8.87
research and development expenses	2058000000	1126000000	82.77
operating expenses	134811000000	128683000000	4.76
interest income	1550000000	714000000	117.09
interest expense	187000000	72000000	159.72
ebitda	40116000000	51254000000	-21.73
ebitdaratio	0.11	0.15	-24.60
operating income	32558000000	44333000000	-26.56
operating income ratio	0.09	0.13	-29.26
net income	14912000000	49264000000	-69.73
net income ratio	0.04	0.14	-70.84
eps	124.3	411.62	-69.80

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 356,344 million in 2024 from 343,267 million in 2023 representing a change of 3.81%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 2,058 million in 2024 from 1,126 million in 2023 representing a change of 82.77%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 163,676 million in 2024 from 173,016 million in 2023 representing a change of -5.4%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 134,811 million in 2024 from 128,683 million in 2023 representing a change of 4.76%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 40,116 million in 2024 from 51,254 million in 2023 representing a change of -21.73%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 32,558 million in 2024 from 44,333 million in 2023 representing a change of -26.56%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 14,912 million in 2024 from 49,264 million in 2023 representing a change of -69.73%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 124.3 in 2024 from 124.3 in 2023 representing a change of -69.8%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	69915000000	98732000000	-29.19
gross profit	40661000000	31750000000	28.07
gross profit ratio	0.58	0.32	80.85
research and development expenses	0	634000000	-100.00
operating expenses	29817000000	34111000000	-12.59
interest income	388000000	577000000	-32.76
interest expense	35000000	49000000	-28.57
ebitda	12735250000	-191000000	6,767.67
ebitdaratio	0.18	-0.0	9,515.90
operating income	10844000000	-2361000000	559.30
operating income ratio	0.16	-0.02	748.61
net income	10620000000	-11856000000	189.57
net income ratio	0.15	-0.12	226.50
eps	88.51	-98.83	189.56

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 69,915 million in 2025Q1 from 98,732 million in 2024Q4 representing a change of -29.19%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 634 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 40,661 million in 2025Q1 from 31,750 million in 2024Q4 representing a change of 28.07%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 29,817 million in 2025Q1 from 34,111 million in 2024Q4 representing a change of -12.59%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 12,735 million in 2025Q1 from -191 million in 2024Q4 representing a change of 6767.67%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 10,844 million in 2025Q1 from -2,361 million in 2024Q4 representing a change of 559.3%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 10,620 million in 2025Q1 from -11,856 million in 2024Q4 representing a change of 189.57%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 88.51 in 2025Q1 from 88.51 in 2024Q4 representing a change of 189.56%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	410876000000	400591000000	2.57
total liabilities	93747000000	83322000000	12.51
total equity	317129000000	317266000000	-0.04
cash and cash equivalents	225901000000	190903000000	18.33
short term investments	2720000000	2598000000	4.70
long term investments	5900000000	4629000000	27.46
total current assets	339219000000	342258000000	-0.89
total non current assets	72711000000	58333000000	24.65
total current liabilities	81559000000	71704000000	13.74
total non current liabilities	12188000000	11618000000	4.91
common stock	24039000000	24039000000	0.00
retained earnings	254741000000	255151000000	-0.16
total debt	2155000000	2168000000	-0.60

Overall Score of Annual Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 410,876 million in 2024 from 400,591 million in 2023 representing a change of 2.57%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 225,901 million in 2024 from 190,903 million in 2023 representing a change of 18.33%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 2,720 million in 2024 from 2,598 million in 2023 representing a change of 4.7%. This indicates an increase in short-term investment holdings.

  Total Debt: Total Debt decreased to 2,155 million in 2024 from 2,168 million in 2023 representing a change of -0.6%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 93,747 million in 2024 from 83,322 million in 2023 representing a change of 12.51%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 317,129 million in 2024 from 317,266 million in 2023 representing a change of -0.04%. This indicates a decrease in shareholders' equity.

  Total Current Assets: Total Current Assets decreased to 339,219 million in 2024 from 342,258 million in 2023 representing a change of -0.89%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 81,559 million in 2024 from 71,704 million in 2023 representing a change of 13.74%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 254,741 million in 2024 from 255,151 million in 2023 representing a change of -0.16%. This indicates an accumulated losses.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	413270000000	411930000000	0.33
total liabilities	88296000000	94799000000	-6.86
total equity	324974000000	317129000000	2.47
cash and cash equivalents	225915000000	223181000000	1.23
short term investments	0	2720000000	-100.00
long term investments	40743000000	5900000000	590.56
total current assets	343259000000	339219000000	1.19
total non current assets	70011000000	72711000000	-3.71
total current liabilities	76105000000	81559000000	-6.69
total non current liabilities	12191000000	13240000000	-7.92
common stock	24039000000	24039000000	0.00
retained earnings	262003000000	254741000000	2.85
total debt	1994000000	2155000000	-7.47

Overall Score of Quarterly Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 413,270 million in 2025Q1 from 411,930 million in 2024Q4 representing a change of 0.33%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 88,296 million in 2025Q1 from 94,799 million in 2024Q4 representing a change of -6.86%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 324,974 million in 2025Q1 from 317,129 million in 2024Q4 representing a change of 2.47%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 225,915 million in 2025Q1 from 223,181 million in 2024Q4 representing a change of 1.23%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 343,259 million in 2025Q1 from 339,219 million in 2024Q4 representing a change of 1.19%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 76,105 million in 2025Q1 from 81,559 million in 2024Q4 representing a change of -6.69%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 262,003 million in 2025Q1 from 254,741 million in 2024Q4 representing a change of 2.85%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 1,994 million in 2025Q1 from 2,155 million in 2024Q4 representing a change of -7.47%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 0 million in 2025Q1 from 2,720 million in 2024Q4 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	32278000000	30280000000	6.60
operating cash flow	52238000000	12226000000	327.27
free cash flow	41791000000	3677000000	1,036.55
capital expenditure	-10447000000	-8549000000	-22.20
depreciation and amortization	7557000000	6921000000	9.19
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	765000000	-5455000000	114.02
inventory	18344000000	-13711000000	233.79
acquisitions net	-190000000	36798000000	-100.52
investments in property plant and equipment	-9285000000	-8549000000	-8.61
net cash used for investing activites	-13214000000	27602000000	-147.87
debt repayment	0	0	NaN
common stock issued	0	354000000	-100.00
common stock repurchased	-3000000	-5000000	40.00
dividends paid	-14838000000	-15418000000	3.76
net cash used provided by financing activities	-14787000000	-15523000000	4.74
cash at end of period	223181000000	190903000000	16.91
accounts receivables	-3508000000	6463000000	-154.28
cash at beginning of period	190903000000	160623000000	18.85

Overall Score of Annual Cashflow Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 32,278 million in 2024 from 30,280 million in 2023 representing a change of 6.6%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 52,238 million in 2024 from 12,226 million in 2023 representing a change of 327.27%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 41,791 million in 2024 from 3,677 million in 2023 representing a change of 1036.55%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -10,447 million in 2024 from -8,549 million in 2023 representing a change of -22.2%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 765 million in 2024 from 5,455 million in 2023 representing a change of 114.02%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -3,508 million in 2024 from 6,463 million in 2023 representing a change of -154.28%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -14,838 million in 2024 from -15,418 million in 2023 representing a change of 3.76%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	0	0	NaN
free cash flow	0	0	NaN
capital expenditure	0	0	NaN
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	0	NaN
net change in cash	0	0	NaN
cash at end of period	0	0	NaN
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	2970.33	2868.11	3.56
net income per share	124.3	411.62	-69.80
operating cash flow per share	435.43	102.15	326.26
free cash flow per share	348.35	30.72	1,033.86
cash per share	1905.69	1616.77	17.87
book value per share	2643.45	2650.89	-0.28
tangible book value per share	2594.43	2601.96	-0.29
shareholders equity per share	2641.33	2649.01	-0.29
interest debt per share	6.69	4.65	43.64
market cap	705855808341.36	762341207516.48	-7.41
enterprise value	482109808341.36	573606207516.48	-15.95
pe ratio	47.33	15.47	205.89
price to sales ratio	1.98	2.22	-10.81
pocfratio	13.51	62.35	-78.33
pfcf ratio	16.89	207.33	-91.85
pb ratio	2.23	2.4	-7.36
ptb ratio	2.23	2.4	-7.36
ev to sales	1.35	1.67	-19.04
enterprise value over ebitda	12.02	11.19	7.38
ev to operating cash flow	9.23	46.92	-80.33
ev to free cash flow	11.54	156.0	-92.60
earnings yield	0.02	0.06	-67.31
free cash flow yield	0.06	0.0	1,127.50
debt to equity	0.0	0.0	26.87
debt to assets	0.0	0.0	23.63
net debt to ebitda	-5.58	-3.68	-51.47
current ratio	4.16	4.77	-12.86
interest coverage	174.11	615.74	-71.72
income quality	3.5	0.25	1,311.58
dividend yield	0.02	0.02	3.94
payout ratio	1.0	0.31	217.94
sales general and administrative to revenue	0.15	0.16	-11.39
research and ddevelopement to revenue	0.01	0.0	76.06
intangibles to total assets	0.01	0.01	-2.09
capex to operating cash flow	0.2	0.7	-71.40
capex to revenue	0.03	0.02	17.72
capex to depreciation	1.38	1.24	11.92
stock based compensation to revenue	0	0	NaN
graham number	2717.93	4953.13	-45.13
roic	0.09	0.12	-27.50
return on tangible assets	0.04	0.12	-70.50
graham net net	1628.5	1557.24	4.58
working capital	257660000000	270554000000	-4.77
tangible asset value	311248000000	311413000000	-0.05
net current asset value	245472000000	258936000000	-5.20
invested capital	286616000000	294153000000	-2.56
average receivables	42057500000	42176500000	-0.28
average payables	23971000000	25578000000	-6.28
average inventory	73605000000	97435500000	-24.46
days sales outstanding	45.54	42.16	8.01
days payables outstanding	46.19	50.51	-8.54
days of inventory on hand	102.86	199.2	-48.37
receivables turnover	8.01	8.66	-7.42
payables turnover	7.9	7.23	9.33
inventory turnover	3.55	1.83	93.67
roe	0.05	0.16	-69.71
capex per share	87.08	71.43	21.91

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-03-31 from 0.16 on 2023-03-31, representing a change of -69.71%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 4.16 on 2024-03-31 from 4.77 on 2023-03-31, representing a change of -12.86%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 47.33 on 2024-03-31 from 15.47 on 2023-03-31, representing a change of 205.89%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-03-31 from 0.00 on 2023-03-31, representing a change of 26.87%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q1	2024-03-31 Q4	Q/Q change %
SQNXF
calendar year	2025	2024	NaN
revenue per share	582.69	823.03	-29.20
net income per share	88.51	-98.83	189.56
operating cash flow per share	0	0	NaN
free cash flow per share	0	0	NaN
cash per share	1882.84	1883.12	-0.02
book value per share	2708.42	2643.62	2.45
tangible book value per share	2658.83	2594.59	2.48
shareholders equity per share	2706.16	2641.48	2.45
interest debt per share	0.29	5.54	-94.73
market cap	582201284325.45	705815552000.28	-17.51
enterprise value	358280284325.45	484789552000.28	-26.10
pe ratio	13.71	-14.88	192.09
price to sales ratio	8.33	7.15	16.48
pocfratio	0	0	NaN
pfcf ratio	0	0	NaN
pb ratio	1.79	2.23	-19.50
ptb ratio	1.79	2.23	-19.50
ev to sales	5.12	4.91	4.37
enterprise value over ebitda	28.13	-2538.17	101.11
ev to operating cash flow	0	0	NaN
ev to free cash flow	0	0	NaN
earnings yield	0.02	-0.02	208.59
free cash flow yield	0	0	NaN
debt to equity	0	0.0	-100.00
debt to assets	0	0.0	-100.00
net debt to ebitda	-17.58	1157.2	-101.52
current ratio	4.51	4.16	8.44
interest coverage	309.83	-48.18	743.02
income quality	0	0	NaN
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0.01	-100.00
research and ddevelopement to revenue	0	0.01	-100.00
intangibles to total assets	0.01	0.01	0.85
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	2321.47	2423.62	-4.21
roic	0.02	-0.0	684.20
return on tangible assets	0.03	-0.03	189.30
graham net net	1657.99	1597.15	3.81
working capital	267154000000	257660000000	3.68
tangible asset value	319024000000	311250000000	2.50
net current asset value	254963000000	244420000000	4.31
invested capital	296421000000	286616000000	3.42
average receivables	41551000000	46427500000	-10.50
average payables	24434000000	23964000000	1.96
average inventory	59484000000	76980000000	-22.73
days sales outstanding	49.74	40.53	22.73
days payables outstanding	75.33	32.76	129.91
days of inventory on hand	198.97	72.95	172.74
receivables turnover	1.81	2.22	-18.52
payables turnover	1.19	2.75	-56.50
inventory turnover	0.45	1.23	-63.34
roe	0.03	-0.04	187.42
capex per share	0	0	NaN

• Negative

  ROE: Return on Equity (ROE) increased to 0.03 on 2024-06-30 Q1 from -0.04 on 2024-03-31 Q4, representing a change of 187.42%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 4.51 on 2024-06-30 Q1 from 4.16 on 2024-03-31 Q4, representing a change of 8.44%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 13.71 on 2024-06-30 Q1 from -14.88 on 2024-03-31 Q4, representing a change of 192.09%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-06-30 Q1 from 0.00 on 2024-03-31 Q4, representing a change of -100.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 50.36 which is higher than current price 37.05, indicates the company may be undervalued.